Table 1.
Correlation between WIPF1 expression and clinicopathological characteristics
| Variables | WIPF1 expression |
Total | χ2 | p-value | |
|---|---|---|---|---|---|
| Low (n = 24) | High (n = 66) | ||||
| Age (year) | 0.417 | 0.518 | |||
| <60 | 9 (37.5) | 20 (30.3) | 29 | ||
| ≥60 | 15 (62.5) | 46 (69.7) | 61 | ||
| Sex | 1.023 | 0.312 | |||
| Female | 10 (41.7) | 20 (30.3) | 30 | ||
| male | 14 (58.3) | 46 (69.7) | 60 | ||
| Tumor size | 0.877 | 0.349 | |||
| <5cm | 9 (37.5) | 18 (27.3) | 27 | ||
| ≥5cm | 15 (62.5) | 48 (72.7) | 63 | ||
| Grade stage | 1.790 | 0.181 | |||
| I/II | 3 (12.5) | 17 (25.8) | 20 | ||
| III/IV | 21 (87.5) | 49 (74.2) | 70 | ||
| TNM stage | 4.574 | 0.032 | |||
| Ι/II | 11 (45.8) | 15 (22.7) | 26 | ||
| III/IV | 13 (54.2) | 51 (77.3) | 64 | ||
| T stage | 0.395 | 0.530 | |||
| T1/T2/T3 | 17 (70.8) | 51 (77.3) | 68 | ||
| T4 | 7 (29.2) | 15 (22.7) | 22 | ||
| N stage | 5.448 | 0.020 | |||
| N0 | 12 (50.0) | 16 (24.2) | 28 | ||
| N1/N2/N3 | 12 (50.0) | 50 (75.8) | 62 | ||
| M stage | 0.368 | 0.544 | |||
| M0 | 24 (100.0) | 65 (98.5) | 89 | ||
| M1 | 0 (0) | 1 (1.5) | 1 | ||